Neutralization activity of IgG antibody in COVID‑19‑convalescent ...

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluated the anti-SARS-CoV-2 antibody ...

Neutralization of SARS-CoV-2 with IgG from COVID-19 ... - Nature

SARS-CoV-2-neutralizing activity and SARS-CoV-2-S1-binding antibody amounts in IgG fractions from COVID-19-convalescent patients. We then ...

Evolution of neutralizing antibodies and cross-activity against ...

Understanding the trends of anti-spike IgG and neutralizing antibody titers in patients recovering from COVID-19 may inform the decision made on the appropriate ...

Temporal maturation of neutralizing antibodies in COVID-19 ...

The persistence of mutation-resistant IgG antibodies contributes to sustaining neutralizing activities to SARS-CoV-2 variants, additively with the ...

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG ...

In convalescent COVID-19 individuals, serum antibody levels against the spike and RBD proteins have been correlated to SARS-CoV-2–seroneutralizing activities ( ...

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 ...

... antibody in hospitalized COVID-19 patients, HCWs, and convalescent plasma donors. ... neutralization IC50 and N protein IgG antibody ELISA ...

Convalescent human IgG, but not IgM, from COVID-19 survivors ...

... neutralizing antibody activity correlates with reduced disease. Other research has also suggested a role for Spike-specific binding antibodies ...

Standardized two-step testing of antibody activity in COVID-19 ...

To calibrate antibody neutralizing activity in serum from convalescent plasma donors, we introduce a neutralizing antibody standard reagent ...

High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding ...

COVID 19-convalescent individuals possess serum virus-neutralizing activity. Abstract. Background. Antibody testing can easily evaluate the ...

Neutralizing activity to SARS‐CoV‐2 in 1.2 to 10.0 month ...

3.1 Study cohort characteristics ; Antibody detection in COVID-19 CPS, Count /% ; Neutralizing antibodies (NAbs), 86.0 (97.7%) ; Immunoglobulin G ( ...

Monoclonal antibodies constructed from COVID-19 convalescent ...

(H) The percentage of COVID-19 convalescent serum IgG antibody with neutralizing activity for MERS-CoV and SARS-CoV-2 spike pseudoviruses. ID50> ...

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent ...

Though vaccines elicit a strong and protective immune response, and transfusion of CCP with high titers of neutralization activity are ...

Neutralization activity of IgG antibody in COVID‑19‑convalescent ...

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants. January 2023; Scientific Reports 13(1):1263.

Neutralization activity of IgG antibody in COVID‑19‑convalescent ...

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants. Kiyoto Tsuchiya,. Kenji Maeda,. Kouki ...

Neutralization of SARS-CoV-2 with IgG from COVID-19 ...

While there are various attempts to administer COVID-19-convalescent plasmas to SARS-CoV-2-infected patients, neither appropriate approach nor clinical ...

Neutralization and Binding Capability of Sars-Cov-2 Variants By/Of ...

... Igg Antibodies of Early Covid-19 Convalescent Inactivated Sera Based on Indirect Elisa ... Keywords: SARS-CoV-2, neutralization, early COVID-19, ...

(PDF) Neutralization of SARS-CoV-2 with IgG from COVID-19 ...

ing activity during clinical courses) lose their neutralizing activity during convalescent periods or a er discharge. No evidence of antibody‑ ...

Preserved SARS-CoV-2 neutralizing IgG activity of in-house ...

We manufactured convalescent plasma against COVID-19 without fast-freezing. •. Neutralizing activities were maintained before and after freezing ...

Comparison of IgG and neutralizing antibody responses after one or ...

Studies of vaccine effectiveness that focus on convalescent patients who were hospitalized for more serious COVID-19, or samples enriched with ...